New strains of the human pathogen responsible for African sleeping sickness can arise by swapping genes between human and animal variants of the parasite, new research from the University of Bristol has found. BRISTOL, 14-5-2015 — /EuropaWire/ — African sleeping … Read the full press release
14-6-2013 — /europawire.eu/ — Researchers at the University of Copenhagen, in collaboration with Seattle Biomedical Research Institute, the University of Oxford, NIMR Tanzania and Retrogenix LTD, have identified how malaria parasites growing inside red blood cells stick to the sides of … Read the full press release
Posted in Denmark, Education, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged Assistant Professor Louise Turner, Assistant Professor Thomas Lavstsen, blood vessels, combat malaria, DRUGS, endothelial, endothelial protein C, EPCR, malaria, Malaria parasites, malaria symptoms, NIMR Tanzania, parasite, parasite proteins, PfEMP1, regulating blood coagulation, Retrogenix LTD, Seattle Biomedical Research Institute, University of Copenhagen, University of Oxford, vaccines
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
